Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Merck Tbk. (MERK) vs Graha Mitra Asia Tbk. (RELF) Price & Performance

Merck Tbk.Trade
Graha Mitra Asia Tbk.Trade

Price performance (Past 24H)

Key statistics

Merck Tbk. vs Graha Mitra Asia Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Graha Mitra Asia Tbk. trades at Rp37 (market cap 223.39B, 6.4M 24h volume). The key difference: Merck Tbk. is far larger — about 7.9× Graha Mitra Asia Tbk.'s market cap, and Graha Mitra Asia Tbk. is more actively traded (6.4M versus 63K). Which is the better fit depends on your goals.

MERKRELF
Market Cap
1.76T223.39B
Volume
63K6.4M
Lot
63063.97K
Turnover
243.97M237.95M
Average Price
3,872.4637.2
Value
243.97M237.95M
Indicative Equilibrium Price
3,90037
Indicative Equilibrium Volume
16.03K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MERK
View details
RELF
View details

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK

About Graha Mitra Asia Tbk.

PT Graha Mitra Asia Tbk (hereinafter referred to as the "Company") was established based on Deed No. 15 dated 17 April 2018 issued by Notary Susi Aprilina, SH MKn. The Company started its commercial operations in 2018.

Read more on RELF